Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

8.61USD
15 Oct 2018
Change (% chg)

$-0.11 (-1.26%)
Prev Close
$8.72
Open
$8.72
Day's High
$8.80
Day's Low
$8.59
Volume
153,389
Avg. Vol
171,054
52-wk High
$18.78
52-wk Low
$7.34

Chart for

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $894.46
Shares Outstanding(Mil.): 47.15
Dividend: --
Yield (%): --

Financials

  AKBA.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -3.62 -- --
ROI: -85.01 1.70 14.60
ROE: -147.39 3.17 16.33

Ex-Akebia employee jailed for night as insider trading trial starts

BOSTON A former Akebia Therapeutics Inc employee accused of engaging in an insider trading scheme must spend a night in jail after he violated a U.S. judge's order and spoke to a witness at the start of his trial on Tuesday.

27 Jun 2018

CORRECTED-Ex-Akebia employee jailed for night as insider trading trial starts

BOSTON, June 26 A former Akebia Therapeutics Inc employee accused of engaging in an insider trading scheme must spend a night in jail after he violated a U.S. judge's order and spoke to a witness at the start of his trial on Tuesday.

27 Jun 2018

BRIEF-Akebia Therapeutics Reports Q1 Loss Per Share $0.48

* AKEBIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $195.59 -1.80
Johnson & Johnson (JNJ.N) $133.95 +0.08
Roche Holding Ltd. (ROG.S) CHF235.25 -0.30
Roche Holding Ltd. (RO.S) CHF236.60 +0.60
FibroGen Inc (FGEN.OQ) $49.67 -0.12
AstraZeneca plc (AZN.L) 5,619.00 +73.00
Astellas Pharma Inc (4503.T) ¥1,849 +20.00
GlaxoSmithKline plc (GSK.L) 1,463.60 +34.20
Bayer AG (BAYGn.DE) €78.07 +1.97
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates